Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for ...

A rare case of skin cancer in a 55-year-old xeroderma pigmentosum patient highlights the persistent, lifelong risk of UV-induced malignancies in this photosensitive genodermatosis.

Surgery is a mainstay treatment for head and neck squamous cell carcinoma (HNSCC). However, the clinical challenge is to ...

Immunotherapy shows promise in reducing recurrence rates for high-risk skin cancer, despite mixed results in recent clinical ...

Panelists discuss how the PODIUM-303 study demonstrated improved progression-free survival (9.3 vs 7.4 months) and response rates (56% vs 44%) when adding retifanlimab to carboplatin-paclitaxel in ...